BGLC
BioNexus Gene Lab·NASDAQ
--
--(--)
--
--(--)
BGLC fundamentals
BioNexus Gene Lab (BGLC) released its earnings on Nov 20, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Nov 20, 2023
EPS
Actual | |
Forecast | |
Surprise | 0.00% |
Revenue
Actual | -- |
Forecast | -- |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in BioNexus Gene Lab's revenue and profit?What does BioNexus Gene Lab do and what are its main business segments?What guidance did BioNexus Gene Lab's management provide for the next earnings period?What were the key takeaways from BioNexus Gene Lab’s earnings call?What is BioNexus Gene Lab's latest dividend and current dividend yield?What is the market's earnings forecast for BioNexus Gene Lab next quarter?What is BioNexus Gene Lab's gross profit margin?Did BioNexus Gene Lab beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
